This approval follows the priority review status by the National Medical Products Administration (“NMPA”) and marks the first nationwide regulatory approval for TAZVERIK ® in China.
This approval follows the priority review status by the National Medical Products Administration ("NMPA”) and marks the first nationwide regulatory approval for TAZVERIK ® in China. The conditional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback